 |
allogeneic ex-vivo expanded placental adherent stromal cells |
|---|---|
| Trade Name | |
| Orphan Indication | For the treatment of severe preeclampsia |
| USA Market Approval | USA |
| USA Designation Date | 2015-12-29 00:00:00 |
| Sponsor | Pluristem Therapeutics, Inc;MATAM Advanced Technology Park, Building # 5;Haifa |
